FIGURE

Fig. 6

ID
ZDB-FIG-180611-16
Publication
She et al., 2017 - Targeting erythropoietin protects against proteinuria in type 2 diabetic patients and in zebrafish
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Apoptosis inhibition treatment partially rescued pronephros phenotype induced by EPO inactivation. A. Normalization of enlarged glomerulus (white arrow head) and shortened pronephric neck (white asterisks) in EPO MO. and EPOR MO. zebrafish embryos treated at 24 hpf with zVAD-fmk (300 μM) for 24 h. White scale bar: 200 μm. B. Quantification of data shown in Figure A performed in three independent experiments. (n = 40–52 embryos per group). **p ≤ 0.01 or ***p < 0.001 as indicated. C. Elevated loss of 70 kDa dextran–FITC fluorescence at 24 hpi and 48 hpi in EPO MO. zebrafish embryos was rescued by zVAD-fmk treatment (n = 41–43 embryos per group). Significance was given for EPO MO. against Control MO. as ***p < 0.001, and EPO MO. + zVAD-fmk against EPO MO. as ###p < 0.001. D. Elevated loss of 70 kDa dextran–FITC fluorescence at 24 hpi and 48 hpi in EPOR MO. zebrafish embryos was rescued by zVAD-fmk incubation (n = 41–47 embryos per group). Same Control MO. and Control MO. + zVAD-fmk were applied. Significance was given for EPOR MO. against Control MO. as ***p < 0.001, and EPOR MO. + zVAD-fmk against EPOR MO. as ##p < 0.01 as indicated. All data were analyzed using the Student‘s t-test. Mean ± s.e.m.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Condition:
Knockdown Reagents:
Observed In:
Stage Range: Long-pec to Day 5

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mol Metab